Possible mechanisms for induction of oxidative stress and suppression of systemic nitric oxide production caused by exposure to environmental chemicals

Environmental Health and Preventive Medicine

Volumn 7, Issue 4, 2002, Pages 141-150

  Kumagai, Yoshito ^a   Shimojo, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cardiovascular dysfunction; Metabolic activation; Nitric oxide; Oxidative stress; Redox cycling

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ANTIOXIDANT; ARSENIC; ENVIRONMENTAL CHEMICAL; MORPHINE DERIVATIVE; MORPHINONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

BLOOD VESSEL TONE; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR DISEASE; COVALENT BOND; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; EXHAUST GAS; MACROMOLECULE; METABOLIC ACTIVATION; MORTALITY; NEUROTOXICITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; VASCULAR DISEASE;

EID: 0036746564     PISSN: 1342078X     EISSN: None     Source Type: Journal    
DOI: 10.1265/ehpm.2002.141     Document Type: Review

References (93)

1. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem. Res. Toxicol. 2000; 13: 135-160.
2. Finkel T. Redox-dependent signal transduction. FEBS Lett. 2000; 476: 52-54.
3. Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 1992; 112: 2-16.
4. O'Brien PJ. Molecular mechanism of quinone cytotoxicity. Chem.-Biol. Interact. 1991; 80: 1-41.
5. Misra AL, Woods LA. Evidence for interaction in vitro of morphine with glutathione. Nature 1970; 228: 1226-1227.
6. Nagamatsu K, Kido Y, Terao T, Ishida T, Toki S. Effect of morphinone on opiate receptor binding and morphine-elicited analgesia. Life Sci. 1982; 31: 1451-1457.
7. Nagamatsu K, Kido Y, Terao T, Ishida T, Toki S. Protective effect of sulfhydryl compounds on acute toxicity of morphinone. Life Sci. 1982; 30: 1121-1127.
8. Yamano S, Kageura E, Ishida T, Toki S. Purification and characterization of guinea pig liver morphine 6-dehydrogenase. J. Biol. Chem. 1985; 260: 5259-5264.
9. Kumagai Y, Ishida T, Toki S. Method for determination of morphinone in urine and bile of guinea pig by high-performance liquid chromatography. J. Chromatogr. 1987; 421: 155-160.
10. Ishida T, Kumagai Y, Ikeda Y, Ito K, Yano M, Toki S, Mihashi K, Fujioka T, Iwase Y, Hachiyama S. (8S)-(glutathion-S-yl)dihydromorphinone, a novel metabolite of morphine from guinea pig bile. Drug. Metab. Dispos. 1989; 17: 77-81.
11. Ishida T, Kumagai Y, Ikeda Y, Ito K, Yano M, Hachiyama S, Toki S. Typical molecular ion peak analysis of morphinone- and codeinone-glutathione adducts with sodium iodide using fast atom bombardment spectrometry. Organic. Mass. Spectrometry 1989; 24: 286-288.
12. Kumagai Y, Todaka T, Toki S. A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig. J. Pharmacol. Exp. Ther. 1990; 255: 504-510.
13. Kumagai Y, Todaka T, Yamano S, Toki S. Stimulation mechanism of guinea pig liver-mediated reduction of naloxone by morphine. Drug. Metab. Dispos. 1990; 18: 462-466.
14. Barnes DM. New data intensify the agony over ecstasy. Science 1988; 239: 864-866.
15. Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 1985; 229: 986-988.
16. Schmidt CJ, Taylor VL. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons. Eur. J. Pharmacol. 1988; 156: 121-131.
17. Hiramatsu M, Kumagai Y, Unger SE, Cho AK. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther. 1990; 254: 521-527.
18. Kumagai Y, Wickham KA, Schmitz DA, Cho AK. Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Participation of different cytochrome P450 isozymes in the demethylenation reaction. Biochem. Pharmacol. 1991; 42: 1061-1067.
19. Lin LY, Kumagai Y, Cho AK. Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes. Chem. Res. Toxicol. 1992; 5: 401-406.
20. Kumagai Y, Lin LY, Hiratsuka A, Narimatsu S, Suzuki T, Yamada H, Oguri K, Yoshimura H, Cho AK. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. Mol. Pharmacol. 1994; 45: 359-365.
21. Patel N, Kumagai Y, Unger SE, Fukuto JM, Cho AK. Transformation of dopamine and alpha-methyldopamine by NG108-15 cells: formation of thiol adducts. Chem. Res. Toxicol. 1991; 4: 421-426.
22. Segura M, Ortuno J, Farre M, McLure JA, Pujadas M, Pizarro N, Llebaria A, Joglar J, Roset PN, Segura J, de La Torre R. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4- methylenedioxymethamphetamine (MDMA) metabolite in humans. Chem. Res. Toxicol. 2001; 14: 1203-1208.
23. Moore HW, Czerniak R. Naturally occurring quinones as potential bioreductive alkylating agents. Med. Res. Rev. 1981; 1: 249-280.
24. Bachur NR, Gordon SL, Gee MV. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res. 1978; 38: 1745-1750.
25. Kumagai Y, Tsurutani Y, Shinyashiki M, Homma-Takeda S, Yoshikawa T, Nakai Y, Shimojo N. Bioactivation of lapachol responsible for DNA scission by NADPH-cytochrome P450 reductase. Environ. Toxicol. Pharmacol. 1997; 3: 245-250.
26. Hathaway JA. Trinitrotoluene: a review of reported dose-related effects providing documentation for a workplace standard. J. Occup. Med. 1977; 19: 341-345.
27. Harkonen H, Karki M, Lahti A, Savolainen H. Early equatorial cataracts in workers exposed to trinitrotoluene. Am. J. Ophthalmol. 1983; 95: 807-810.
28. Srivastava SK, Ansari NH, Bhatnagar A. Sugar induced cataractogenesis: a paradigm of oxidative tissue pathology? Lens Eye Toxic. Res. 1990; 7: 161-171.
29. Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J. 1995; 9: 1173-1182.
30. Zitting A, Szumanska G, Nickels J, Savolainen H. Acute toxic effects of trinitrotoluene on rat brain, liver and kidny: role of radical production. Arch. Toxicol. 1982; 51; 53-64.
31. Kumagai Y, Wakayama T, Li S, Shinohara A, Iwamatsu A, Sun GF, Shimojo N. ξ-crystallin catalyzes the reductive activation of 2,4,6-trinitrotoluene to generate reactive oxygen species: a proposed mechanism for the induction of cataracts. FEBS Lett. 2000; 478: 295-298.
32. Schuetzle D, Lee FSC, Prater TJ. The identification of polynuclear aromatic hydrocarbon derivatives in mutagenic fractions of diesel exhaust particulate extracts. Int. J. Environ. Anal. Chem. 1981; 9: 1-93.
33. Schuetzle D. Sampling of vehicle emissions for chemical analysis and biological testing. Environ. Health Perspect. 1983; 47: 65-80.
34. McClellan RO. Health effects of exposure to diesel exhaust particles. Ann. Rev. Pharmacol. Toxicol. 1987; 27: 279-300.
35. Nel AE, Diaz-Sanchez D, Li N. The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr. Opin. Pulm. Med. 2001; 7: 20-26.
36. Sagai M, Saito H, Ichinose T, Kodama M, Mori Y. Biological effects of diesel exhaust particles. I. In vitro production of superoxide and in vivo toxicity. Free Rad. Biol. Med. 1993; 14: 37-47.
37. Hiura TS, Kaszubowski MP, Li N, Nel, AE. Chemicals in diesel exhaust particles generate reactive oxygen radicals and induce apoptosis in macrophages. J. Immunol. 1999; 163: 5582-5591.
38. Li N, Venkatesan MI, Miguel A, Kaplan R, Gujuluva C, Alam J, Nel AE. Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J. Immunol. 2000; 165; 3393-3401.
39. Takizawa H, Ohtoshi T, Kawasaki S, Abe S, Sugawara I, Nakahara K, Matsushima K, Kudoh S. Diesel exhaust particles activate human bronchial epithelial cells to express inflammatory mediators in the airways: a review. Respirology 2000; 5: 197-203.
40. Gavett SH, Koren HS. The role of particulate matter in exacerbation of atopic asthma. Int. Arch. Allergy Immunol. 2001; 124: 109-112.
41. Nagashima M, Kasai H, Yokota J, Nagamachi Y, Ichinose T, Sagai M. Formation of an oxidative DNA damage, 8-hydroxydeoxyguanosine, in mouse lung DNA after intratracheal instillation of diesel exhaust particles and effects of high dietary fat and beta-carotene on this process. Carcinogenesis 1995; 16: 1441-1445.
42. Kasai H, Nishimura S (1984) Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucl. Acid. Res. 1984; 12: 2137-2145.
43. Casillas AM, Hiura T, Li N, Nel AE. Enhancement of allergic inflammation by diesel exhaust particles: permissive role of reactive oxygen species. Ann. Allergy Asthma. Immunol. 1999; 83: 624-629.
44. Kumagai Y, Arimoto T, Shinyashiki M, Shimojo N, Nakai Y, Yoshikawa T, Sagai M. Generation of reactive oxygen species during interaction of diesel exhaust particles components with NADPH-cytochrome P450 reductase and involvement of the bioactivation in the DNA damage. Free Rad. Biol. Med. 1997; 22: 479-487.
45. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109-142.
46. Stuehr DJ. Structure-function aspects in the nitric oxide synthases. Annu. Rev. Pharmacol. Toxicol. 1997; 37: 339-359.
47. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714-718.
48. Luo D, Vincent SR. Inhibition of nitric oxide synthase by antineoplastic anthracyclines. Biochem. Pharmacol. 1994; 47: 2111-2112.
49. Kumagai Y, Nakajima H, Midorikawa K, Homma-Takeda S, Shimojo N. Inhibition of nitric oxide formation by neuronal nitric oxide synthase by quinones: Nitric oxide synthase as a quinone reductase. Chem. Res. Toxicol. 1998; 11: 608-613.
50. Abu-Soud HM, Stuehr DJ. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad. Sci. USA 1993; 90: 10769-10772.
51. Abu-Soud HM, Yoho LL, Stuehr DJ. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. Activation of intra- and interdomain electron transfer. J. Biol. Chem. 1994; 269: 32047-32050.
52. 2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. J. Biol. Chem. 1992; 267: 11374-11378.
53. Vásquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA Jr, Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 1997; 36: 11293-11297.
54. 2+/ calmodulin-independent diaphorase and reductase activities. Biochemistry 1992; 31: 3243-3249.
55. Matsuda, H, Kimura, S, and Iyanagi T. One-electron reduction of quinones by the neuronal nitric-oxide synthase reductase domain. Biochim. Biophys. Acta. 2000; 1459: 106-116.
56. Dockery DW, Pope CA III, Xu X, Spengler, JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE. An association between air pollution and mortality in six U.S. cities. N. Engl. J. Med. 1993; 329, 1753-1759.
57. Pope CA III, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW Jr. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am. J. Respir. Crit. Care Med. 1995; 151: 669-674.
58. Borja-Aburto VH, Castillejos M, Gold DR, Bierzwinski S, Loomis D. Mortality and ambient fine particles in southwest Mexico City, 1993-1995. Environ. Health Perspect. 1998; 106: 849-855.
59. Ikeda M, Suzuki M, Watarai K, Sagai M, Tomita T. Impairment of endothelium-dependent relaxation by diesel exhaust particles in rat thoracic aorta. Jpn. J. Pharmacol. 1995; 68: 183-189.
60. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992; 6: 3051-3064.
61. Rees DD, Palmer RMJ, Moncada S. Role of endotheliumderived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 1989; 86: 3375-3378.
62. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242.
63. Umans JG, Levi R. Nitric oxide in the regulation of blood flow and arterial pressure. Annu. Rev. Physiol. 1995; 57: 771-790.
64. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ. Res. 1996; 79: 363-380.
65. Kumagai Y, Hayashi T, Miyauchi T, Endo A, Iguchi A, KiriyaSakai M, Sakai S, Yuki K, Kikushima M, Shimojo N. Phnanthraquinone inhibits eNOS activity and suppresses vasorelaxation. Am. J. Physiol. 2001; 281: R25-R30.
66. Grange DL, Anstey NM, Miller WC, Weinberg JB. Measuring nitric oxide production in human clinical studies. Method Enzymol. 1997; 301: 49-61.
67. Kumagai Y, Koide S, Taguchi K, Endo A, Nakai Y, Yoshikawa T, Shimojo N. Oxidation of proximal protein sulfhydryls by phenanthraquinone, a component of diesel exhaust particles. Chem. Res. Toxicol. 2002; 15: 483-489.
68. Wardman P. Reduction potentials of one-electron couples involving free radicals in aqueous solution. J. Phys. Chem. Ref. Data 1989; 18: 1637-1755.
69. Murphy ME, Piper HM, Watanabe H, Sies H. Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J. Biol. Chem. 1991; 266: 19378-19383.
70. Zembowicz A, Hatchett RJ, Radziszewsi W, Gryglewsi RJ. Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiol suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase. J. Pharmacol. Exp. Ther. 1993; 267: 1112-1117.
71. Marczin N, Ryan US, Catravas JD. Sulfhydryl-depleting agents, but not deferoxamine, modulated EDRF action in cultured pulmonary arterial cells. Am. J. Physiol. 1993; 265: L220-L227.
72. Patel JM, Block ER. Sulfhydryl-disulfide modification and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 1995; 13: 352-359.
73. Taguchi K, Kumagai Y, Endo A, Kikushima M, Ishii Y, Shimojo N. Phenanthraquinone affects endothelial nitric oxide synthase activity through modification of the thiol groups: an alternative inhibition mechanism. J. Health Sci. 2001; 47: 571-574.
74. Davidge ST, Ojimba J, McLaughlin MK. Vascular function in the vitamin E-deprived rat: an interaction between nitric oxide and superoxide anions. Hypertension 1998; 31: 830-835.
75. World Health Organization. Environmental Health Criteria. 18: Arsenic. Geneva, Switzerland: World Health Organization. 43-102; 1981.
76. 3) on cultured human umbilical vein endothelial cells. J. Dermatol. 1990; 17: 599-608.
77. Wang TS, Kuo CF, Jan KY, Huang H. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell Physiol. 1996; 169: 256-268.
78. Ramos O, Carrizales L, Yanez L, Mejia J, Batres L, Ortiz D, Diaz-Barriga F. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environ. Health Perspect. 1995; 103: 85-88.
79. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood. 1999; 94: 2102-2111.
80. Liu SX, Athar M, Lippai I, Waldren C, Hei TK. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. USA 2001; 98: 1643-1648.
81. Delnomdedieu M, Basti MM, Styblo M, Otvos JD, Thomas DJ. Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 1994; 7: 621-627.
82. Winski SL, Carter DE. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J. Toxicol. Environ. Health 1995; 46: 379-397.
83. Uckun FM, Liu XP, D'Cruz OJ. Human sperm immobilizing activity of aminophenyl arsenic acid and its N-substituted quinazoline, pyrimidine, and purine derivatives: protective effect of glutathione. Reprod. Toxicol. 2002; 16: 57-64.
84. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impared nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997; 95: 2068-2074.
85. Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H, Endo A, Yu L, Yuki K, Miyauchi T, Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Rad. Biol. Med. 2000; 28: 1137-4112.
86. Pi JB, Yamauchi H, Kumagai Y, Sun GF, Yoshida T, Aikawa H, Hopenhayn-Rich C, Shimojo N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ. Health Perspect. 2002; 110: 331-336.
87. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J. 1992; 281: 627-630.
88. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 1992; 267: 24173-24176.
89. Pi JB, Kumagai Y, Nikaido, M, Yamauchi H, Horiguchi S, Ishii Y, Sun GF, Shimojo N. A mechanism for the impairment of nitric oxide formation and induction of oxidative stress caused by prolonged arsenic exposure. 10th International Symposium on Natural and Industrial Arsenic Japan; 2001, 31-32 (abstract).
90. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage applications in experimental animals and in humans. Free Rad. Biol. Med. 1999; 26: 202226.
91. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett. 2000; 486: 10-13.
92. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am. J. Physiol. 1989; 257: H33-37.
93. Lawson DL, Mehta JL, Nichols WW, Mehta P, Donnelly WH. Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings. J. Lab. Clin. Med. 1990; 115: 541-548.